Encompass health corporation announces execution of supplemental indenture for its 4.500% senior notes due 2028, 4.750% senior notes due 2030 and 4.625% senior notes due 2031
Birmingham, ala., jan. 25, 2022 /prnewswire/ -- encompass health corporation ("encompass health" or the "company") (nyse: ehc), a national leader in integrated healthcare, offering facility-based and home-based patient care through its network of inpatient rehabilitation hospitals and home health and hospice agencies, today announced that it has received the required consents (the "required consents") from holders of its 4.500% senior notes due 2028 (the "2028 notes"), 4.750% senior notes due 2030 (the "2030 notes") and 4.625% senior notes due 2031 (the "2031 notes" and together with the 2028 notes and 2030 notes, the "notes") to certain proposed amendments (the "proposed amendments") described in the consent solicitation statement, dated december 9, 2021 (as amended on december 16, 2021, january 12, 2022, january 18, 2022 and january 20, 2022, the "statement") to the indenture governing the notes (the "indenture").
EHC Ratings Summary
EHC Quant Ranking
You've reached your free article limit.
Want To Read More Articles?
See what it all means for your stocks with premium tools
Stockprices is a weekly video covering what moved markets
this week, featuring a panel of Stockprices editors. It is published by the
close of trading on Fridays. Hosted by Nathaniel E. Baker, contributing editor,
and featuring: Aaron Task, VP Contributor Content and co-host Stockprices's Alpha
Trader podcast; Brad Olesen, VP News; Steve Alpher, Managing Editor News, co-host
Alpha Trader.
Unsubscribe From All
You successfully activated
“Only Essentials”
Confirm Upgrade
Your subscription will be moved to the annual plan. Service will automatically renew unless cancelled. No Refunds. Click upgrade to confirm.
Stockprices uses Plaid to connect you account
Connect effortlessly
Plaid lets you securely connect your financial accounts in seconds
Your data belongs to you
Plaid doesn't sell personal info, and will only use it with your permission